NCT05316389 Retrospective and Prospective Evaluation of Scapulohumeral Comfort, Aesthetic Result and Quality of Life Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05316324 A Study of the Use of Acellular Dermal Matrix for Breast Reconstruction Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05315154 Sentinel Lymph Node Biopsy Versus no Axillary Surgery in Early Breast Cancer Status ACTIVE_NOT_RECRUITING Phase NA
NCT05315011 Assessment of Cryotherapy's Analgesic Impact in Anti-aromatase-induced Arthralgia Status SUSPENDED Phase NA
NCT05313191 Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors Status RECRUITING Phase NA
NCT05311618 Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05311397 A Study of A166 in Patients With Advanced Solid Malignant Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05309265 Vocational Rehabilitation for the Return to Work of Breast Cancer Patients: a Feasibility Study Status ACTIVE_NOT_RECRUITING Phase NA
NCT05309252 The Unmet Needs and the Workplace Reintegration of Breast Cancer Patients: the NEW-BreCa Project Status COMPLETED Phase N/A
NCT05307757 Screening Contralateral Breast Cancers in Patients With Newly Diagnosed Breast Cancer Status RECRUITING Phase N/A
NCT05307705 A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05306600 Onco-Genomas Brasil: Mapping Breast and Prostate Cancer in the Brazilian Public Health System Status RECRUITING Phase N/A
NCT05305365 Study Assessing QBS72S For Treating Brain Metastases Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05304962 FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer Status RECRUITING Phase PHASE1
NCT05303129 Prognostic Impact of the Neutrophil/Lymphocyte Ratio (NLR) in the Treatment of First-line Metastatic or Locally Advanced Breast Cancer Treated With CDK4/6 Inhibitor. Status COMPLETED Phase NA